Saturday, February 25, 2012

Restylane: new news or old snooze?


Stop the press! The FDA clears Restylane as the first filler approved for lip augmentation. We can all sleep better tonight. After 1000s of lip enhancement injections without any hiccups, I do not think this will change the market at all. Is it good to know? Perhaps you will be on Jeopardy?
As we age there are changes we see in the lip. The aged lip loses volume and it becomes thinner. The cupid’s bow (philtrum) becomes flatter, and the lip will actually lengthen and show less upper teeth at rest. The lip liner area becomes less defined and woman often complain that their lipstick bleeds. Vertical lines in the white portion of the lip also are a common complaint. Many young people alike, just want a fuller lip as a result of the growing trend in beauty thanks to our idols like Angelina.
Hyaluronic acid fillers are the most common filler used to correct these changes in the lip. This is a natural substance found in skin and works to trap water and plump skin, thus while you’ll often find it in your everyday moisturizer. Such fillers include Restylane®, Perlane, and Juvederm®. These are all FDA approved fillers for wrinkles and creases, but only Restylane® is FDA approved for the lip. Comparing these three products, Restylane is a jello like consistency that typically lasts for 6 months. Perlane is a larger molecule that lasts longer than Restylane® but can be prone to lumpiness as a result of its size. Juvederm® is typically my go to filler for lips as the results are smooth and it is a concentrated form of hyaluronic acid that can last up to a year.
Lip enhancement is an easy procedure that yields beautiful results. The treatment is painless after getting the area numb and there is little to no downtime. Should the recent FDA approval lean you, the patient, more towards the path of Restylane? How many of you have had Botox injections? Did you know it is only FDA approved for frown lines?

0 Comments:

Post a Comment

Subscribe to Post Comments [Atom]

<< Home